Shomron Ben-Horin

21PUBLICATIONS
43CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Immunogenetics (incl. genetic immunology)Predictive and prognostic markersInfant and child healthCondensed matter imaging
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Sep 09, 2026
Long-term real-world effectiveness and safety of mirikizumab in ulcerative colitis: 52-Week results from an expanded international two-center retrospective cohort study.

|Jul 15, 2026
The Israeli IBD Research Nucleus: collaborative advancements in Israeli IBD research.

|Mar 25, 2026
Pharmacokinetics and efficacy of subcutaneous infliximab 120 mg every 2 weeks: a post hoc comparison with intravenous dosing in a phase 1 study in patients with inflammatory bowel disease.

Stefan Schreiber, Byong Duk Ye, Hyunseong Yu

|Nov 28, 2025
One Subcutaneous 2-ml Injection of Mirikizumab is Bioequivalent to Two 1-ml Subcutaneous Injections in Healthy Participants.

Yuki Otani, Christopher D Payne, Edward V Loftus

|Nov 13, 2025
Mirikizumab in ulcerative colitis: real-world evidence from an international two-center retrospective cohort study.

Asaf Levartovsky, Martin Lukáš, Chaya Mushka Abitbol

|Jun 11, 2025
Intestinal ultrasound measurement of bowel wall thickness can be used as a sole marker for defining anti-TNF maintenance therapy failure in Crohn's disease.

Ahmad Albshesh, Shadi Haj, Ido Veisman

Pageof 4

Frequent Collaborators

7 joint publications

Uri Kopylov

3 joint publications

Bella Ungar

2 joint publications

Ido Veisman

2 joint publications

Xavier Roblin